SUBSCRIBERS
Cordlife proposes to merge with NY-listed life sciences enterprise
Published Tue, Jun 4, 2019 · 09:50 PM
Singapore
CORDLIFE Group on Tuesday said that it has made an indicative, non-binding and conditional proposal to merge with New York-listed Global Cord Blood Corporation.
Global Cord Blood Corporation provides cord blood collection, laboratory testing, haematopoietic stem cell processing …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Syngenta to withdraw China IPO application on weak market: sources
Chinese firms’ fundraisings in limbo as IPOs scrutinised at home and abroad
China’s Huawei continues rebound with strongest earnings growth since 2019
Hatten Land gets notice of default, letter of demand for RM14 million, appoints financial adviser
ComfortDelGro wins contracts to run buses in Manchester
Sam Bankman-Fried, at sentencing, acknowledges FTX customers have suffered